News about Market

Samsung Bioepis Launches First Biosimilar Product in Japan with Ustekinumab Therapy

Samsung Bioepis launches its ustekinumab biosimilar in Japan through a partnership with Nipro Corporation, expanding access to affordable treatments for chronic autoimmune diseases.

Market | 21/05/2026 | By News Bureau |  178

Dr. Reddy's Launches Oral Semaglutide Biosimilar Obeda Tablets in India

Dr. Reddy's launches Obeda oral semaglutide tablets in India, strengthening its GLP-1 portfolio after recent generic semaglutide injection launches in India and Canada for diabetes and obesity care.

Market | 20/05/2026 | By News Bureau |  260

InMed Pharmaceuticals and Mentari Therapeutics Mergers to Advance Next-Generation Migraine Therapies

InMed Pharmaceuticals and Mentari Therapeutics have entered into a definitive merger agreement, combining Mentari’s migraine-focused drug pipeline with InMed’s public market infrastructure to support the development of innovative therapies targeting chronic and episodic migraine.

Market | 20/05/2026 | By News Bureau |  358

Zydus Lifesciences Completes Investment in Torrent Urja 25 with Rs 90.18 Million Share Subscription

Zydus Lifesciences and its subsidiaries have completed the final tranche of investment in Torrent Urja 25, subscribing to equity shares worth Rs 90.18 million and concluding the transaction initiated under the Share Subscription and Shareholders’ Agreements (SSSAs).

Market | 20/05/2026 | By News Bureau |  194

Indian Pharmacist Association Distances Itself From Proposed Nationwide Pharmacy Strike

Indian Pharmacist Association has announced that it will not support the nationwide pharmacy strike called by All India Organisation of Chemists and Druggists, joining several state-level trade and pharmacist bodies that have rejected the bandh.

Market | 19/05/2026 | By News Bureau |  233

NIH-Backed Researchers Launch Open-Access Tool to Improve Amblyopia Care in Children

Researchers supported by the National Institutes of Health have introduced the Amblyopia Navigator Decision-Support Instrument (ANDI), an open-access tool designed to support evidence-based treatment of amblyopia in children.

Market | 18/05/2026 | By News Bureau |  142

Glenmark Pharmaceuticals Launches Vancomycin for Injection USP in US

Glenmark Pharmaceuticals launches Vancomycin Hydrochloride for Injection USP in the US market, expanding its injectable portfolio in a segment valued at nearly USD 37.9 million annually.

Market | 18/05/2026 | By News Bureau |  154

OrganaBio Acquires Excellos Assets to Establish Bicoastal Cell Therapy Manufacturing Platform

The acquisition expands cGMP manufacturing, PBMC isolation and cryopreservation capabilities across the US to support cell therapy developers from preclinical to commercial stages.

Market | 16/05/2026 | By News Bureau |  146

Dyno Therapeutics Unveils Next-Generation AI-Engineered AAV Capsids for CNS and Muscle Gene Delivery

Dyno Therapeutics introduced new AAV gene delivery capsids for central nervous system and muscular applications, highlighting enhanced cross-species transduction, reduced liver targeting and scalable manufacturing potential for next-generation genetic medicines.

Market | 16/05/2026 | By News Bureau |  335

Dr. Reddy's Launches Generic Semaglutide Injection in Canada

Dr. Reddy's Laboratories launches Canada’s first approved generic semaglutide injection after receiving Health Canada clearance, marking the first G7 market authorisation.

Market | 16/05/2026 | By News Bureau |  284